skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: HEAL-Link subscriptions: Lippincott Williams & Wilkins remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone

Shah, Amil M ; Claggett, Brian ; Sweitzer, Nancy K ; Shah, Sanjiv J ; Anand, Inder S ; Liu, Li ; Pitt, Bertram ; Pfeffer, Marc A ; Solomon, Scott D

Circulation (New York, N.Y.), 2015-08, Vol.132 (5), p.402-414 [Periódico revisado por pares]

United States: by the American College of Cardiology Foundation and the American Heart Association, Inc

Texto completo disponível

Citações Citado por
2
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

Rossignol, Patrick ; Dobre, Daniela ; McMurray, John J V ; Swedberg, Karl ; Krum, Henry ; van Veldhuisen, Dirk J ; Shi, Harry ; Messig, Michael ; Vincent, John ; Girerd, Nicolas ; Bakris, George ; Pitt, Bertram ; Zannad, Faiez

Circulation. Heart failure, 2014-01, Vol.7 (1), p.51-58 [Periódico revisado por pares]

United States: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
3
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

Chapman, Neil ; Dobson, Joanna ; Wilson, Sarah ; Dahlöf, Björn ; Sever, Peter S ; Wedel, Hans ; Poulter, Neil R

Hypertension (Dallas, Tex. 1979), 2007-04, Vol.49 (4), p.839-845 [Periódico revisado por pares]

United States: American Heart Association, Inc

Texto completo disponível

Citações Citado por
4
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
Material Type:
Artigo 		Adicionar ao Meu Espaço

Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury

Kolkhof, Peter ; Delbeck, Martina ; Kretschmer, Axel ; Steinke, Wolfram ; Hartmann, Elke ; Bärfacker, Lars ; Eitner, Frank ; Albrecht-Küpper, Barbara ; Schäfer, Stefan

Journal of cardiovascular pharmacology, 2014-07, Vol.64 (1), p.69-78 [Periódico revisado por pares]

United States: by Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
5
CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY
CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY
Material Type:
Artigo 		Adicionar ao Meu Espaço

CENTRAL SEROUS CHORIORETINOPATHY TREATED WITH MINERALOCORTICOID ANTAGONISTS: A ONE-YEAR PILOT STUDY

Ghadiali, Quraish ; Jung, Jesse J ; Yu, Suqin ; Patel, Samir N ; Yannuzzi, Lawrence A

Retina (Philadelphia, Pa.), 2016-03, Vol.36 (3), p.611-618 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response
Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response
Material Type:
Artigo 		Adicionar ao Meu Espaço

Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response

Martin-Lorenzo, Marta ; Martinez, Paula J ; Baldan-Martin, Montserrat ; Ruiz-Hurtado, Gema ; Prado, Jose Carlos ; Segura, Julian ; de la Cuesta, Fernando ; Barderas, Maria G ; Vivanco, Fernando ; Ruilope, Luis Miguel ; Alvarez-Llamas, Gloria

Hypertension (Dallas, Tex. 1979), 2017-11, Vol.70 (5), p.1049-1056 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses
Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses

Roush, George C ; Ernst, Michael E ; Kostis, John B ; Yeasmin, Shamima ; Sica, Domenic A

Journal of hypertension, 2016-01, Vol.34 (1), p.11-19 [Periódico revisado por pares]

England: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponível

Citações Citado por
8
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial

Pfeffer, Marc A ; Claggett, Brian ; Assmann, Susan F ; Boineau, Robin ; Anand, Inder S ; Clausell, Nadine ; Desai, Akshay S ; Diaz, Rafael ; Fleg, Jerome L ; Gordeev, Ivan ; Heitner, John F ; Lewis, Eldrin F ; O'Meara, Eileen ; Rouleau, Jean-Lucien ; Probstfield, Jeffrey L ; Shaburishvili, Tamaz ; Shah, Sanjiv J ; Solomon, Scott D ; Sweitzer, Nancy K ; McKinlay, Sonja M ; Pitt, Bertram

Circulation (New York, N.Y.), 2015-01, Vol.131 (1), p.34-42 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
9
Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone
Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone

Good, Miranda E ; Chiu, Yu-Hsin ; Poon, Ivan K H ; Medina, Chris ; Butcher, Joshua T ; Mendu, Suresh K ; DeLalio, Leon J ; Lohman, Alexander W ; Leitinger, Norbert ; Barrett, Eugene ; Lorenz, Ulrike M ; Desai, Bimal N ; Jaffe, Iris Z ; Bayliss, Douglas A ; Isakson, Brant E ; Ravichandran, Kodi S

Circulation research, 2018-02, Vol.122 (4), p.606-615 [Periódico revisado por pares]

United States: American Heart Association, Inc

Texto completo disponível

Citações Citado por
10
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice

DeMarco, Vincent G ; Habibi, Javad ; Jia, Guanghong ; Aroor, Annayya R ; Ramirez-Perez, Francisco I ; Martinez-Lemus, Luis A ; Bender, Shawn B ; Garro, Mona ; Hayden, Melvin R ; Sun, Zhe ; Meininger, Gerald A ; Manrique, Camila ; Whaley-Connell, Adam ; Sowers, James R

Hypertension (Dallas, Tex. 1979), 2015-07, Vol.66 (1), p.99-107 [Periódico revisado por pares]

United States: American Heart Association, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (502)

Data de Publicação 

De até
Refinar
  1. Antes de1977  (29)
  2. 1977Até1990  (27)
  3. 1991Até2001  (46)
  4. 2002Até2013  (268)
  5. Após 2013  (137)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.